CORE--DEVELOPMENTAL

核心--发展

• 批准号: 6989932
• 负责人: Franklyn G Prendergast
• 金额: $ 20万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-09-15 至 2009-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6989932
• 关键词: biomedical facility; health science research support; neoplasm /cancer; oncology; training

DESCRIPTION (provided by applicant): The MCCC considers the developmental funds as one of the most critical components of CCSG support. Together with institutionally derived Cancer Center discretionary funds and the annual grant support from the Fraternal Order of Eagles, these funds provide seed monies necessary to either initiate research projects or generate pilot data for subsequent grant applications. It should not be surprising, given the small size of the developmental fund pool ($175,000/yr) relative to the substantial expansion realized over the last funding period, that Mayoprovided discretionary funds have contributed more than 90% of the monies needed for seed or pilot projects, for program or shared resource initiation, and all funds for instrumentation and new laboratory set-up costs. Funding is requested in the next project period to support initiatives in the following categories: new cores; equipment; recruitment; and pilot projects. The Cancer Center's review and planning process is rigorous. Investigator-initiated and programmatic proposals must demonstrate a clear probable trajectory for sustained peer reviewed funding, and proposals for enhancement of our shared resources must be for quality services or technologies that address a critical current or projected need - they must add value. The Center has also recognized the importance of these funds in support of high risk projects that might otherwise not be accorded funding through traditional peer review. These projects are particularly encouraged by the MCCC. Nonetheless, they must meet the same scientific standards as other proposals as a prerequisite for funding consideration.

描述(由申请人提供)：MCCC认为发展基金是CCSG支持的最关键的组成部分之一。这些基金与机构派生的癌症中心可自由支配基金和老鹰兄弟会的年度赠款支持一起，提供启动研究项目或为随后的赠款申请生成试点数据所需的种子资金。考虑到发展基金池的规模很小(175,000美元/年)，相对于上一个资助期实现的大幅扩张，这并不令人惊讶，梅奥提供的可自由支配基金贡献了种子或试点项目、计划或共享资源启动所需资金的90%以上，以及用于仪器和新实验室建立成本的所有资金。在下一个项目期需要资金，以支持下列类别的举措：新的核心、设备、征聘和试点项目。癌症中心的审查和规划过程是严格的。由调查员发起的方案提案必须表明持续同行审查供资的明确可能轨迹，而加强我们共享资源的提案必须是满足当前或预计关键需求的高质量服务或技术--它们必须增加价值。该中心还认识到这些资金在支持高风险项目方面的重要性，否则这些项目可能得不到通过传统同行审查提供的资金。这些项目尤其受到MCCC的鼓励。尽管如此，它们必须达到与其他提案相同的科学标准，作为考虑资助的先决条件。